These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1672980)

  • 1. Medical oncology in the 1990s.
    Braverman AS
    Lancet; 1991 Apr; 337(8746):901-2. PubMed ID: 1672980
    [No Abstract]   [Full Text] [Related]  

  • 2. Translational research in oncology comes timely.
    Chow LW; Toi M
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S263. PubMed ID: 16507388
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies for medical oncology: a few critical perspectives.
    Belda-Iniesta C; Ibáñez de Cáceres I; de Castro J
    Clin Transl Oncol; 2011 Feb; 13(2):84-7. PubMed ID: 21324795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights of the American Society of Clinical Oncology annual meeting 2005. 13-17 May, 2005, Florida, USA.
    Burstein HJ
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):581-3. PubMed ID: 16111459
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination therapies in oncology.
    Webster RM
    Nat Rev Drug Discov; 2016 Feb; 15(2):81-2. PubMed ID: 26837588
    [No Abstract]   [Full Text] [Related]  

  • 6. [The current potentials and outlook for drug therapy in oncology].
    Gershanovich ML; Borisov VI; Sidorenko IuS; Tiuliandin SA; Gorbunova VA
    Vopr Onkol; 1995; 41(2):116-24. PubMed ID: 7483406
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional cancer therapy: promise broken or promise delayed?
    Tannock IF
    Lancet; 1998 May; 351 Suppl 2():SII9-16. PubMed ID: 9606361
    [No Abstract]   [Full Text] [Related]  

  • 9. International Clinical Trials in Radiation Oncology. Chemical modifiers.
    Bartelink H; Bleehen NM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S39-49. PubMed ID: 3292481
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent advances in medical oncology--1995-1996.
    Sikov WM
    Med Health R I; 1996 Mar; 79(3):92-9. PubMed ID: 8901289
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlights from the 29th European Society for Medical Oncology Congress: Vienna, Austria, October 29 through November 2, 2004.
    Price N
    Clin Prostate Cancer; 2004 Dec; 3(3):136-40. PubMed ID: 15636678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments].
    Jochims C; Mazitschek U; Jäger D; Goldschmidt H
    Internist (Berl); 2006 Jun; 47(6):633-41. PubMed ID: 16767478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Servier's pipeline in oncology: moving from research to patients.
    Therasse P; Abastado JP
    Future Oncol; 2016 Mar; 12(5):589-94. PubMed ID: 26764971
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuro-oncology 1999.
    Rosenberg RN
    Arch Neurol; 1999 Apr; 56(4):397-8. PubMed ID: 10199325
    [No Abstract]   [Full Text] [Related]  

  • 15. [New therapeutic strategies in oncology].
    Bohuon C
    Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
    Masters GA; Krilov L; Bailey HH; Brose MS; Burstein H; Diller LR; Dizon DS; Fine HA; Kalemkerian GP; Moasser M; Neuss MN; O'Day SJ; Odenike O; Ryan CJ; Schilsky RL; Schwartz GK; Venook AP; Wong SL; Patel JD
    J Clin Oncol; 2015 Mar; 33(7):786-809. PubMed ID: 25605863
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction and commentary: paving the way for biosimilars in oncology, part 2: focus on safety and clinical trial considerations.
    Abraham J
    Semin Oncol; 2014 Feb; 41 Suppl 1():S1-2. PubMed ID: 24560023
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical oncology considerations in patients with metastatic neuroendocrine carcinomas.
    Kvols L
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):56-60. PubMed ID: 7992083
    [No Abstract]   [Full Text] [Related]  

  • 19. Introduction and commentary: Paving the way for biosimilars in oncology.
    Abraham J
    Semin Oncol; 2013 Dec; 40 Suppl 1():S1-4. PubMed ID: 24267943
    [No Abstract]   [Full Text] [Related]  

  • 20. New Agents in Clinical Oncology. 24 November 2006, London, UK.
    Martin S
    IDrugs; 2007 Feb; 10(2):99-101. PubMed ID: 17285459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.